Cabenuva Interactions
There are 456 drugs known to interact with Cabenuva (cabotegravir/rilpivirine), along with 6 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 152 are major, 303 are moderate, and 1 is minor.
- View all 456 medications that may interact with Cabenuva
- View Cabenuva alcohol/food interactions (2)
- View Cabenuva disease interactions (6)
Most frequently checked interactions
View interaction reports for Cabenuva (cabotegravir / rilpivirine) and the medicines listed below.
- albuterol
- amlodipine
- atorvastatin
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- bupropion
- cetirizine
- clonazepam
- cyclobenzaprine
- Descovy (emtricitabine / tenofovir alafenamide)
- Dovato (dolutegravir / lamivudine)
- doxycycline
- Flonase (fluticasone nasal)
- fluticasone nasal
- gabapentin
- hydroxyzine
- ibuprofen
- Jardiance (empagliflozin)
- lisinopril
- losartan
- metformin
- Mounjaro (tirzepatide)
- omeprazole
- Ozempic (semaglutide)
- pantoprazole
- rosuvastatin
- tadalafil
- trazodone
- valacyclovir
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Cabenuva alcohol/food interactions
There are 2 alcohol/food interactions with Cabenuva (cabotegravir / rilpivirine).
Cabenuva disease interactions
There are 6 disease interactions with Cabenuva (cabotegravir / rilpivirine) which include:
More about Cabenuva (cabotegravir / rilpivirine)
- Cabenuva consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (24)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.